Brief: Prophase Labs Announces Collaboration For Development Of Pre-Cancer Diagnostic Screening Test
March 1 (Reuters) - Prophase Labs Inc PRPH.O :
* PROPHASE LABS ANNOUNCES COLLABORATION WITH MPROBE, INC.
AND MAYO
CLINIC FOR THE CONTINUING DEVELOPMENT OF BE-SMART ESOPHAGEAL
PRE-CANCER DIAGNOSTIC SCREENING TEST
* PROPHASE LABS INC - INTENDS TO PURSUE INITIAL
COMMERCIALIZATION
OF BE-SMART TEST AS LABORATORY DEVELOPED TEST & FOR RESEARCH USE
ONLY IN Q3 OF 2023
Source text for Eikon: ID:nGNX4c7N1b
Further company coverage: PRPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prophase Labs
See all newsBrief: Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:29 PM